Concepedia

Xiaobin Chi

XC

Statistics

Publications

4

Citations

52

H-Index

4

Active since

2019

Affiliations

Fujian Medical University(Current)

Xiaobin Chi is an author at Fujian Medical University specializing in gene expression, molecular biology, and tumor progression.

Publications per year

2019–2023

4

Publications

4

Glycochenodeoxycholic acid impairs transcription factor E3 -dependent autophagy-lysosome machinery by disrupting reactive oxygen species homeostasis in L02 cells

Weifeng Lan, Zhijian Chen, Yongtai Chen et al. · Toxicology Letters · 2020 · 16 citations

, , +14

Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study

Yongbiao Chen, Hanyin Hong, Wenzheng Fang et al. · Frontiers in Oncology · 2023 · 14 citations · Full text

, , +17

Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion

Xiaobin Chi, Yiguo Jiang, Yongbiao Chen et al. · Bioengineered · 2021 · 12 citations · Full text

, , +17

Suppression of microRNA‑27a protects against liver ischemia/reperfusion injury by targeting PPARγ and inhibiting endoplasmic reticulum stress

Xiaobin Chi, Yi Jiang, Yongbiao Chen et al. · Molecular Medicine Reports · 2019 · 10 citations · Full text

, , +17

1–4 of 4